MedDataX Logo

Excimer Lamp Versus Excimer Laser in Vitiligo Treatment

NCT ID: NCT00696358

Last Updated: 2008-10-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Study Classification

INTERVENTIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

308 nm excimer lamp and 308 nm excimer laser have both provide interesting results in treating vitiligo. They have the same wavelength but the type of emission of the photons is different. To date there is no direct comparative data concerning these two devices in this indication.

The aim of the study is to make an intra-individual prospective comparison between these two phototherapies.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vitiligo

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Vitiligo

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A

308 nm excimer lamp

Group Type ACTIVE_COMPARATOR

308nm excimer lamp

Intervention Type RADIATION

50 mJ/cm² below the MED (minimal erythemal dose) and progressive increase Twice a week for 12 weeks

B

308 nm excimer laser

Group Type ACTIVE_COMPARATOR

308nm excimer laser

Intervention Type RADIATION

50 mJ/cm² below the MED (minimal erythemal dose) and progressive increase Twice a week for 12 weeks (same doses will be used between the 2 arms)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

308nm excimer lamp

50 mJ/cm² below the MED (minimal erythemal dose) and progressive increase Twice a week for 12 weeks

Intervention Type RADIATION

308nm excimer laser

50 mJ/cm² below the MED (minimal erythemal dose) and progressive increase Twice a week for 12 weeks (same doses will be used between the 2 arms)

Intervention Type RADIATION

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patient above 18
* vitiligo for more than 3 months
* at least 2 vitiligo symmetric patches more than 10cm²
* to read and understand the inform consent
* to have a social security number
* non pregnant for women

Exclusion Criteria

* pregnant women
* keloids
* history of radiotherapy or skin cancer in the treated areas
* treatment for vitiligo in the past 4 weeks
* phototherapy in the past 12 weeks; history of photodermatosis
* treatment inducing photosensibilization
* immunosuppression
* patient who participated in a study in the past 3 months
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de Nice

OTHER

Sponsor Role lead

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Dermatology, University Hospital of Nice

Nice, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NICE-VIT1

Identifier Type: -

Identifier Source: org_study_id